Clinical Outcomes of Switching to Insulin Glargine 300 U/ml from Other Basal Insulins in People with Type 2 Diabetes in Italy: A Real-World Study

INTRODUCTION: Primary aim was to provide real-world evidence of the outcomes after the switch to glargine 300 U/ml (Gla-300) from other basal insulins (first or second generation) in Italy. METHODS: Multicenter, observational, retrospective study based on electronic medical records. RESULTS: Overall...

Descripción completa

Detalles Bibliográficos
Autores principales: Ragonese, Mauro, Larosa, Monica, Angotti, Stefania, Annese, Stefania, Cruciani, Laura, Dainelli, Michela, Lucisano, Giuseppe, Prosperini, Giuseppe, Sacco, Michele, Salomone, Enrica, Saponara, Caterina, Semprini, Roberta, Rossi, Maria Chiara, Nicolucci, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509008/
https://www.ncbi.nlm.nih.gov/pubmed/32813262
http://dx.doi.org/10.1007/s13300-020-00902-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509008/
https://www.ncbi.nlm.nih.gov/pubmed/32813262
http://dx.doi.org/10.1007/s13300-020-00902-1

Ejemplares similares